Navigation Links
Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System
Date:3/7/2011

eived by physicians since their launch in CE Mark countries, and we are pleased to offer a bare-metal coronary stent built on the same PtCr platform," said Mike Phalen, Executive Vice President and President, International for Boston Scientific.  "The OMEGA Stent is the latest example of our commitment to continued innovation in coronary stenting.  We are confident our platinum chromium technology will strengthen our worldwide stent market leadership."  

"The positive clinical data from our PtCr (Element) trials support the acute performance benefits provided by our new platinum chromium stent platform," said Keith D. Dawkins, M.D., Senior Vice President and Chief Medical Officer for Boston Scientific's Cardiology, Rhythm and Vascular Group.  "The OMEGA Stent complements the PtCr Stent series, and gives interventional cardiologists the option to treat patients with a paclitaxel, everolimus or bare-metal stent."

The OMEGA Stent is offered in 48 sizes, ranging in diameter from 2.25 mm to 4.50 mm and lengths of 8 mm to 32 mm.  Boston Scientific has the industry's most comprehensive coronary stent portfolio, offering physicians and their patients the broadest size matrix and the only two-drug platform.  The Company received CE Mark approval for the PROMUS Element Stent System in October 2009 and for the TAXUS Element Stent System in May 2010.  

The TAXUS Element Stent System will be commercialized in the U.S. as the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System and the PROMUS Element Stent System will be commercialized as the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System.  Both systems incorporate the same platinum chromium alloy, innovative stent design and advanced catheter delivery system.

The Company anticipates U.S. Food and Drug Administration approval for the ION Stent System in mid 2011, and mid 2012 approval for the PROMUS Element P
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
2. Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech
3. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
4. Nektar Therapeutics President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
5. Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India
6. Boston Scientific to Participate in 2011 RBC Capital Markets Healthcare Conference
7. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
8. Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine
9. Boston Scientific Welcomes Publication of Gender Data Highlighting Benefits Women Receive From CRT-Ds
10. Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010
11. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego.  ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
(Date:5/23/2013)... May 23, 2013   Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3
... Inc. ("Senesco" or the "Company") (Amex: SNT ... Inc. (The Woodlands, TX) ("VGXI") to,supply the plasmid ... Factor 5A gene and siRNA against Factor 5A., ... vivo results,using its combination siRNA and plasmid against ...
... Continuing Education Newsletter Series for Healthcare ... ... is a serious condition that causes disease with a wide spectrum ... can occur in up to 20% of patients who develop an ...
Cached Medicine Technology:Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2
(Date:5/24/2013)... 2013 Amirsys today announces the release ... for instructors and students. Instructors can use the new ... learning plan templates, targeted reading assignments, and customized instructions. ... assessment questions, 5,000 searchable anatomy glossary terms, and easier ... 2.0 is the first gross anatomy resource to ...
(Date:5/24/2013)... myofibromatosis (IM)a disorder characterized by multiple tumors involving the ... according to researchers from the Icahn School of Medicine ... American Journal of Human Genetics , may lead to ... the only current treatment option is repeated surgical removal ... that develops in infancy or even in utero and ...
(Date:5/24/2013)... May 24, 2013 Mike Stoler believes ... most successful business people in New York. That’s ... airs weekly on CUNY TV. And that’s why ... and Allergy Associates, LLP (ENTA)—the largest single specialty practice ... nose, throat, allergy and audiology specialists and sub-specialists service ...
(Date:5/24/2013)... 6Webs.com has educated thousands of buyers on what ... monitoring provider. The easy to read reviews and ... prefer for unbiased and impartial home security reviews. 6Webs.com ... wireless home security system providers in the nation. The ... of key factors including reliability, technology and equipment. ...
(Date:5/24/2013)... May 24, 2013 The Dictation Source ... base of clients. As a result of its National ... presence in 20 states around the nation. , Since ... transcription services to the healthcare industry . Dictation Source ... use their years of clinical work experience to provide ...
Breaking Medicine News(10 mins):Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3
... to Visit Washington, D.C., and Meet with Elected Officials, ... will travel to Washington, D.C., this April 1 to ... of the,Americans with Disabilities Act, support for epilepsy public ... Serwik, 7, is one of 50 young people ...
... Visit Washington, D.C., and,Meet with Elected Officials, ... Nicklaus Schliesmann of Holmen will travel to Washington,D.C., ... and gain their,support for restoration of the Americans ... and more research toward a cure for,epilepsy., ...
... D.C., and Meet with Elected Officials, WASHINGTON, March ... travel to Washington, D.C., this April 1 to meet ... the,Americans with Disabilities Act, support for epilepsy public health,programs ... Smith, 15, is one of 50 young people with ...
... Corporation,(NYSE: STE ) today announced that its ... to $300 million in shares of STERIS common ... as of,February 29, 2008. This share repurchase authorization ... remaining. Through March,13, 2008, the Company has repurchased ...
... in Handling Credit ... Fraud, ... he has reached a settlement with TransUnion over his,lawsuit against the credit ... is the first of six credit reporting companies and banks,which Drew has ...
... LINTHICUM, Md., March 13 Dialysis Corporation,of America ... that it will begin,hosting conference calls in conjunction ... The conference call will he held,Friday morning, March ... interested may dial in at 800-750-4984 using pass-code ...
Cached Medicine News:Health News:Delaware Youth Named National Epilepsy Spokesperson 2Health News:Wisconsin Youths Named National Epilepsy Spokespersons 2Health News:South Carolina Youth Named National Epilepsy Spokesperson 2Health News:STERIS Corporation Announces New $300 Million Share Repurchase Authorization 2Health News:STERIS Corporation Announces New $300 Million Share Repurchase Authorization 3Health News:Leukemia Survivor Reaches Landmark Settlement With TransUnion in ID Theft Case 2Health News:Dialysis Corporation of America Earnings Call Reminder 2
... panel is designed for medical imaging. The 18 inch ... and ultrasound. It can be mounted on a wall ... It allows for RGB, s-video and composite inputs with ... in VGA input. In VGA mode, its resolution is ...
... fixation. Completely resorbable, it presented surgeons with ... the most thoroughly proven product of its ... with system enhancements that make it even ... system means that application of this proven ...
... The intra-operative MR system ... intra-operative tool for radiologists ... goal of the system ... valuable adjunct to standard ...
... ultrasound A-scan Sonomed-315 is intended for visualization ... detection of midline shifts in the brain, ... and easy to use, the Sonomed-315 offers ... A-scanning mode allows to identify the anatomic ...
Medicine Products: